PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 123 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2015. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $270,000 | +6.7% | 53,000 | +6.0% | 0.00% | -20.0% |
| Q3 2019 | $253,000 | -18.1% | 50,000 | 0.0% | 0.01% | -37.5% |
| Q2 2019 | $309,000 | +66.1% | 50,000 | +25.0% | 0.01% | +60.0% |
| Q1 2019 | $186,000 | -64.3% | 40,000 | -56.0% | 0.01% | -78.3% |
| Q3 2015 | $521,000 | -22.4% | 91,000 | +1.1% | 0.02% | -14.8% |
| Q2 2015 | $671,000 | – | 90,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVERENCE CAPITAL MANAGEMENT INC | 28,980 | $123,000 | 0.01% |
| Daiwa Securities Group Inc. | 533 | $2,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 138,663 | $52,000 | 0.00% |